Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: the CODAM study

Int J Cardiol. 2014 Jun 15;174(2):400-3. doi: 10.1016/j.ijcard.2014.04.057. Epub 2014 Apr 13.
No abstract available

Keywords: Atherosclerosis; Cardiovascular diseases; Complement activation; Endothelial dysfunction; Inflammation.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / blood*
  • Complement C5a / analysis*
  • Complement C5a / physiology*
  • Complement Membrane Attack Complex / analysis*
  • Complement Membrane Attack Complex / physiology*
  • Cross-Sectional Studies
  • Endothelium, Vascular / physiopathology*
  • Female
  • Humans
  • Inflammation / blood*
  • Inflammation / etiology*
  • Male
  • Middle Aged
  • Severity of Illness Index

Substances

  • Complement Membrane Attack Complex
  • SC5b-9 protein complex
  • Complement C5a